Sex offenders, sentencing laws and pharmaceutical treatment: A prescription for failure

T. Howard Stone, William Winslade, Craig M. Klugman

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The phenomenon of adults who have sexual interests involving children as partners, or pedophiles, is considered among the most sociopathological of human conditions. Considerable literature is devoted to issues and problems associated with or related to pedophilia, including prevalence, etiology, treatment, and outcome studies. The sexual victimization of children, based upon data gathered from a number of sources, suggests an intractable problem that is national in scope. Recent manifestations of society's efforts to deal with the sexual victimization of children include the enactment of criminal sentencing laws that mandate the treatment of offenders with certain pharmaceutical agents, such as medroxy-progesterone acetate ('MPA'). Because sentencing laws as a rule vary widely from state to state, there is considerable variation as to who is subject to MPA treatment laws, and how such laws - including specific provisions, such as clinical criteria, if any, required for treatment; type and period of treatment plans; informed consent; etc - are implemented. Most important, these sentencing laws may have remarkably little relation to what is widely considered effective treatment for pedophilia disorders. We examine in detail the most recent sentencing laws pertaining to treatment of persons who have been convicted of sex offenses involving children as victims. Our critique may offer insight and suggestions as to how such sentencing laws can be more suitably tailored to the treatment needs of persons with pedophilia disorders. Copyright (C) 2000 John Wiley and Sons, Ltd.

Original languageEnglish (US)
Pages (from-to)83-110
Number of pages28
JournalBehavioral Sciences and the Law
Volume18
Issue number1
DOIs
StatePublished - 2000

Fingerprint

pharmaceutical
Prescriptions
offender
medication
pedophilia
Pedophilia
Law
Pharmaceutical Preparations
Crime Victims
victimization
Therapeutics
human being
criminal law
Criminal Law
etiology
Sex Offenses
Informed Consent
Progesterone
offense
Acetates

ASJC Scopus subject areas

  • Law
  • Psychology(all)
  • Applied Psychology

Cite this

Sex offenders, sentencing laws and pharmaceutical treatment : A prescription for failure. / Howard Stone, T.; Winslade, William; Klugman, Craig M.

In: Behavioral Sciences and the Law, Vol. 18, No. 1, 2000, p. 83-110.

Research output: Contribution to journalArticle

@article{00a73da97dac4be1a292c51ba34523da,
title = "Sex offenders, sentencing laws and pharmaceutical treatment: A prescription for failure",
abstract = "The phenomenon of adults who have sexual interests involving children as partners, or pedophiles, is considered among the most sociopathological of human conditions. Considerable literature is devoted to issues and problems associated with or related to pedophilia, including prevalence, etiology, treatment, and outcome studies. The sexual victimization of children, based upon data gathered from a number of sources, suggests an intractable problem that is national in scope. Recent manifestations of society's efforts to deal with the sexual victimization of children include the enactment of criminal sentencing laws that mandate the treatment of offenders with certain pharmaceutical agents, such as medroxy-progesterone acetate ('MPA'). Because sentencing laws as a rule vary widely from state to state, there is considerable variation as to who is subject to MPA treatment laws, and how such laws - including specific provisions, such as clinical criteria, if any, required for treatment; type and period of treatment plans; informed consent; etc - are implemented. Most important, these sentencing laws may have remarkably little relation to what is widely considered effective treatment for pedophilia disorders. We examine in detail the most recent sentencing laws pertaining to treatment of persons who have been convicted of sex offenses involving children as victims. Our critique may offer insight and suggestions as to how such sentencing laws can be more suitably tailored to the treatment needs of persons with pedophilia disorders. Copyright (C) 2000 John Wiley and Sons, Ltd.",
author = "{Howard Stone}, T. and William Winslade and Klugman, {Craig M.}",
year = "2000",
doi = "10.1002/(SICI)1099-0798(200001/02)18:1<83::AID-BSL379>3.0.CO;2-W",
language = "English (US)",
volume = "18",
pages = "83--110",
journal = "Behavioral Sciences and the Law",
issn = "0735-3936",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Sex offenders, sentencing laws and pharmaceutical treatment

T2 - A prescription for failure

AU - Howard Stone, T.

AU - Winslade, William

AU - Klugman, Craig M.

PY - 2000

Y1 - 2000

N2 - The phenomenon of adults who have sexual interests involving children as partners, or pedophiles, is considered among the most sociopathological of human conditions. Considerable literature is devoted to issues and problems associated with or related to pedophilia, including prevalence, etiology, treatment, and outcome studies. The sexual victimization of children, based upon data gathered from a number of sources, suggests an intractable problem that is national in scope. Recent manifestations of society's efforts to deal with the sexual victimization of children include the enactment of criminal sentencing laws that mandate the treatment of offenders with certain pharmaceutical agents, such as medroxy-progesterone acetate ('MPA'). Because sentencing laws as a rule vary widely from state to state, there is considerable variation as to who is subject to MPA treatment laws, and how such laws - including specific provisions, such as clinical criteria, if any, required for treatment; type and period of treatment plans; informed consent; etc - are implemented. Most important, these sentencing laws may have remarkably little relation to what is widely considered effective treatment for pedophilia disorders. We examine in detail the most recent sentencing laws pertaining to treatment of persons who have been convicted of sex offenses involving children as victims. Our critique may offer insight and suggestions as to how such sentencing laws can be more suitably tailored to the treatment needs of persons with pedophilia disorders. Copyright (C) 2000 John Wiley and Sons, Ltd.

AB - The phenomenon of adults who have sexual interests involving children as partners, or pedophiles, is considered among the most sociopathological of human conditions. Considerable literature is devoted to issues and problems associated with or related to pedophilia, including prevalence, etiology, treatment, and outcome studies. The sexual victimization of children, based upon data gathered from a number of sources, suggests an intractable problem that is national in scope. Recent manifestations of society's efforts to deal with the sexual victimization of children include the enactment of criminal sentencing laws that mandate the treatment of offenders with certain pharmaceutical agents, such as medroxy-progesterone acetate ('MPA'). Because sentencing laws as a rule vary widely from state to state, there is considerable variation as to who is subject to MPA treatment laws, and how such laws - including specific provisions, such as clinical criteria, if any, required for treatment; type and period of treatment plans; informed consent; etc - are implemented. Most important, these sentencing laws may have remarkably little relation to what is widely considered effective treatment for pedophilia disorders. We examine in detail the most recent sentencing laws pertaining to treatment of persons who have been convicted of sex offenses involving children as victims. Our critique may offer insight and suggestions as to how such sentencing laws can be more suitably tailored to the treatment needs of persons with pedophilia disorders. Copyright (C) 2000 John Wiley and Sons, Ltd.

UR - http://www.scopus.com/inward/record.url?scp=12944281758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944281758&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-0798(200001/02)18:1<83::AID-BSL379>3.0.CO;2-W

DO - 10.1002/(SICI)1099-0798(200001/02)18:1<83::AID-BSL379>3.0.CO;2-W

M3 - Article

C2 - 10736579

AN - SCOPUS:12944281758

VL - 18

SP - 83

EP - 110

JO - Behavioral Sciences and the Law

JF - Behavioral Sciences and the Law

SN - 0735-3936

IS - 1

ER -